Literature DB >> 15125927

Studies on aromatic compounds: inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids.

Ana Montero1, Mercedes Alonso, Esperanza Benito, Antonio Chana, Enrique Mann, José M Navas, Bernardo Herradón.   

Abstract

With the objective to understand structural features responsible for the biological activity, novel nonelectrophilic biphenyl derivatives and peptide-biphenyl hybrids have been synthesized and evaluated as calpain I inhibitors. The preliminary results indicate that the presence of additional aromatic rings (besides the biphenyl system) makes these compounds potent calpain inhibitors with IC50 values in the nanomolar range.

Mesh:

Substances:

Year:  2004        PMID: 15125927     DOI: 10.1016/j.bmcl.2004.03.071

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

2.  Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions.

Authors:  Mona Connolly; Yolanda Pérez; Enrique Mann; Bernardo Herradón; María L Fernández-Cruz; José M Navas
Journal:  Nanoscale Res Lett       Date:  2013-07-06       Impact factor: 4.703

Review 3.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

4.  Ni(ii)-catalyzed mono-selective ortho-arylation of unactivated aryl C-H bonds utilizing amino acids as a directing group.

Authors:  Zhanqing Cong; Feng Gao; Hong Liu
Journal:  RSC Adv       Date:  2019-04-08       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.